Amedisys ROA 2010-2025 | AMED

Current and historical return on assets (ROA) values for Amedisys (AMED) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Amedisys ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $0.09B $2.19B 4.20%
2024-12-31 $0.04B $2.14B 2.03%
2024-09-30 $0.08B $2.14B 3.90%
2024-06-30 $0.09B $2.12B 4.39%
2024-03-31 $-0.02B $2.09B -1.03%
2023-12-31 $-0.01B $2.06B -0.50%
2023-09-30 $0.00B $2.03B 0.15%
2023-06-30 $0.00B $1.98B 0.15%
2023-03-31 $0.11B $1.95B 5.72%
2022-12-31 $0.12B $1.98B 6.10%
2022-09-30 $0.12B $1.98B 6.30%
2022-06-30 $0.14B $2.00B 7.32%
2022-03-31 $0.19B $1.91B 10.46%
2021-12-31 $0.21B $1.86B 12.00%
2021-09-30 $0.22B $1.94B 13.18%
2021-06-30 $0.25B $1.60B 15.58%
2021-03-31 $0.20B $1.57B 12.65%
2020-12-31 $0.18B $1.57B 11.77%
2020-09-30 $0.17B $1.60B 11.23%
2020-06-30 $0.13B $1.65B 9.28%
2020-03-31 $0.13B $1.44B 10.00%
2019-12-31 $0.13B $1.26B 10.44%
2019-09-30 $0.13B $1.21B 11.67%
2019-06-30 $0.12B $1.21B 12.84%
2019-03-31 $0.12B $1.18B 14.44%
2018-12-31 $0.12B $0.72B 15.54%
2018-09-30 $0.09B $0.73B 11.10%
2018-06-30 $0.07B $0.75B 8.85%
2018-03-31 $0.04B $0.84B 5.15%
2017-12-31 $0.03B $0.81B 3.78%
2017-09-30 $0.04B $0.80B 5.55%
2017-06-30 $0.04B $0.81B 5.17%
2017-03-31 $0.05B $0.76B 6.29%
2016-12-31 $0.04B $0.73B 5.15%
2016-09-30 $0.04B $0.72B 5.81%
2016-06-30 $0.04B $0.71B 5.50%
2016-03-31 $0.04B $0.71B 5.63%
2015-12-31 $0.00B $0.68B -0.46%
2015-09-30 $-0.01B $0.67B -1.08%
2015-06-30 $-0.01B $0.65B -1.07%
2015-03-31 $-0.01B $0.62B -1.49%
2014-12-31 $0.01B $0.67B 1.86%
2014-09-30 $-0.01B $0.68B -0.84%
2014-06-30 $-0.11B $0.71B -14.39%
2014-03-31 $-0.11B $0.73B -15.27%
2013-12-31 $-0.10B $0.73B -13.27%
2013-09-30 $-0.19B $0.76B -26.64%
2013-06-30 $-0.09B $0.70B -12.19%
2013-03-31 $-0.09B $0.71B -10.83%
2012-12-31 $-0.08B $0.73B -10.12%
2012-09-30 $0.03B $0.88B 3.13%
2012-06-30 $-0.41B $0.86B -47.63%
2012-03-31 $-0.39B $0.86B -40.30%
2011-12-31 $-0.38B $0.86B -35.03%
2011-09-30 $-0.37B $0.85B -30.32%
2011-06-30 $0.08B $1.34B 6.19%
2011-03-31 $0.09B $1.33B 7.05%
2010-12-31 $0.11B $1.30B 8.94%
2010-09-30 $0.13B $1.26B 10.47%
2010-06-30 $0.14B $1.27B 11.93%
2010-03-31 $0.15B $1.22B 12.67%
2009-12-31 $0.14B $1.17B 12.16%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.201B $2.348B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.779B 17.94
DaVita (DVA) United States $11.021B 15.50
Encompass Health (EHC) United States $10.912B 23.13
Elanco Animal Health (ELAN) United States $7.147B 15.31
Chemed (CHE) United States $6.798B 22.68
Option Care Health (OPCH) United States $4.934B 21.99
RadNet (RDNT) United States $4.242B 269.24
Addus HomeCare (ADUS) United States $1.985B 21.80
LifeStance Health (LFST) United States $1.606B 0.00
Astrana Health (ASTH) United States $1.314B 32.54
U.S Physical Therapy (USPH) United States $1.149B 29.66
Pennant (PNTG) United States $0.792B 29.09
Aveanna Healthcare Holdings (AVAH) United States $0.784B 44.67
Atai Life Sciences (ATAI) Germany $0.663B 0.00
Daxor (DXR) United States $0.050B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.035B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00